Amyloid β -Protein Assembly as a Therapeutic Target of Alzheimers Disease
نویسندگان
چکیده
منابع مشابه
p 87: the amyloid beta as a therapeutic target in alzheimer disease
alzheimer disease (ad) is a neurodegenerative disorder marked by cognitive and behavioral impairment. amyloid beta (aβ) peptides are involved in ad as the main component of amyloid plaques found in the brain. recent in vivo and in vitro studies have shown that there is a lot of substances that alter aβ pathogenesis of ad. aβ induces toxicity lead to increasing ros. in the other hand, 5-ht6 and ...
متن کاملP 86: CD166 as a Therapeutic Target in Autoimmune Diseases
About 3 decades ago CD6 identified as one of the first antigens expresses on the majority of T cells and a subset of B cells. CD6 regulates cellular adhesion migration across the endothelial and epithelial cells. In recent years researches indicate its role in pathogenesis of autoimmune diseases. Many researches have been done in recent years to block CD6 by CD6 mono clonal antibodies, IOR-T1 a...
متن کاملProtein kinase C as a therapeutic target.
The recognition of protein kinase C (PKC) as the long soughtafter receptor for the tumor-promoting phorbol esters established the potential role of PKC in carcinogenesis and as a potentially important target for cancer therapeutics (1, 2). PKC is a family of serine/threonine kinases that regulate a variety of cell functions including proliferation, gene expression, cell cycle, differentiation, ...
متن کاملProtein Kinase D as Novel Therapeutic Target for Neurological Disease
Protein kinase D (PKD) is a novel kinase whose catalytic domain resembles calcium calmodulin kinase and its regulatory domains resemble protein kinase C. We have discovered that (1) PKD is dually regulated by the NMDA and metabotropic glutamate receptors (mGluRs). In turn, PKD regulates AMPAR recycling, especially the GluR2 subunit. (2) We have found that CNS-specific PKD1 deficient mice are vi...
متن کاملAmyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer’s disease
Abnormal elevation of amyloid β-peptide (Aβ) levels in the brain is the primary trigger for neuronal cell death specific to Alzheimer's disease (AD). It is now evident that Aβ levels in the brain are manipulable due to a dynamic equilibrium between its production from the amyloid precursor protein (APP) and removal by amyloid clearance proteins. Clearance can be either enzymic or non-enzymic (b...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Current Pharmaceutical Design
سال: 2008
ISSN: 1381-6128
DOI: 10.2174/138161208786404137